Hepatitis Monthly

Published by: Kowsar

The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis

Mehran Babanejad 1 , Neda Izadi 2 , Farid Najafi 3 and Seyed Moayed Alavian 1 , *
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
3 Department of Epidemiology, Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Hepatitis Monthly: March 01, 2016, 16 (3); e35664
  • Published Online: March 26, 2016
  • Article Type: Review Article
  • Received: December 23, 2015
  • Revised: January 29, 2016
  • Accepted: January 31, 2016
  • DOI: 10.5812/hepatmon.35664

To Cite: Babanejad M, Izadi N, Najafi F, Alavian S M. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis, Hepat Mon. 2016 ; 16(3):e35664. doi: 10.5812/hepatmon.35664.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 2. 2015. Hepatitis B;
  • 3. Emergencies preparedness, response. Hepatitis B. Disease. 2015;
  • 4. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007; 370(9585): 415-26[DOI][PubMed]
  • 5. World Health Organization. Global Database on Blood Safety: Summary Report 2011. 2012;
  • 6. World Health Organization . Blood safety and availability. 2015;
  • 7.
  • 8. The growing threats of hepatitis B and C in the Eastern Mediterranean region: a call for action. 2009;
  • 9. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
  • 10. Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med. 2009; 19(4): 189-94[DOI][PubMed]
  • 11. Mohammadali F, Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. Arch Iran Med. 2014; 17(9): 613-20[PubMed]
  • 12. Tigen ET, Dogru A, Karadag FY. Hepatitis B, Hepatitis C and human immunodeficiency virus prevalences among first time blood donors in Istanbul, Turkey, 2004-2011. Transfus Apher Sci. 2015; 53(2): 176-9[DOI][PubMed]
  • 13. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006; 21(4): 299-305[DOI][PubMed]
  • 14. Dray X, Dray-Spira R, Bronstein JA, Mattera D. Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti [in Frecch]. Med Trop (Mars). 2005; 65(1): 39-42[PubMed]
  • 15. Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis. 2008; 8: 43[DOI][PubMed]
  • 16. Vahid T, Kafaei J, Kabir A, Yektaparast B, Alavian SM. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, Iran. Hakim Res J. 2005; 1(8): 8-15
  • 17. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
  • 18. Adouani B, Alami R, Laouina A, Benahadi A, Boulahdid S, Mokhtari A, et al. Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country. Transfus Med. 2013; 23(6): 432-7[DOI][PubMed]
  • 19. Khmmaj A, Habas E, Azabi M, Rayani A. Frequency of hepatitis B, C, and HIV viruses among blood donors in Libya. Libyan J Med. 2010; 5[DOI][PubMed]
  • 20. Kasraian L, Jahromi ST. Prevalence of major transfusion-transmissible viral infections in blood donors attending fars blood transfusion center, shiraz, southern Iran: 2002–05. Iran J Med Sci. 2015; 32(2): 114-7
  • 21. Ramezani H, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM. Successful exclusion of blood-borne viral disease in blood donors. Eur J Intern Med. 2011; 22(6)-4[DOI][PubMed]
  • 22. Fawzi Z, Al Hilali A, Al Malki A, Al Matawa H, Yousef B, Ali Bin Ali A, et al. Survey of Hepatitis Markers Among Donors in the State of Qatar. Qatar Med J. 2007; 2007(2): 16[DOI]
  • 23. Krichen CH, Rekik H, Feki H, Dammak J, Gargouri J. Prevalence of viral markers among blood donors in Tunisia. Clin Lab. 2001; 47(9-10): 509-16[PubMed]
  • 24. Nagi AM, Altyeb H, Ahmed A. Seroprevalence of Hepatitis B and C Viral Infections among blood donors in Shendi, River Nile State, Sudan. Res J Med Med Sci. 2007; 2(2): 122-6
  • 25. Bani Aghil SS, Abbasi S, Arab M, Seyedein MS. The Prevalence of HCV, HBV, HIV in Blood Donors of Golestan Province, (2006-2008). Med Lab J. 2009; 3(2)
  • 26. Khoufi MT, Mrabet A, Nsiri B, Ebdelli MN, Yedeas M. Epidemiology of hepatitis B in Tunisia: retrospective study in 198157 blood donors in military environment. BMC Infect Dis. 2014; 14: 16[DOI]
  • 27. Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J. 2012; 18(6): 624-9[PubMed]
  • 28. El-Ghitany EM, Farghaly AG. Serological pattern of hepatitis B virus among Hbsag negative blood donors in Alexandria, Egypt. East Mediterr Health J. 2013; 19(7): 600-7[PubMed]
  • 29. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008; 18(1): 55-61[DOI][PubMed]
  • 30. Moniri R, Mosayebii Z, Mossavi GA. Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors. Iranian J Publ Health. 2004; 33(4): 38-42
  • 31. Sallam TA, Tong CY, Cuevas LE, Raja'a YA, Othman AM, Al-Kharsa KR. Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiol Infect. 2003; 131(1): 771-5[PubMed]
  • 32. Abdul Mujeeb S, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc. 2000; 50(8): 269-70[PubMed]
  • 33. Abou MA, Eltahir YM, Ali AS. Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan. Virol J. 2009; 6: 146[DOI][PubMed]
  • 34. Elfaki A, Eldour A, Elsheikh N. Sero-prevalence of immunodeficiency virus, hepatitis B and C and syphilis among blood donors at ElObeid Teaching Hospital, West Sudan. Sudan J Med Sci. 2008; 3(4): 333-8
  • 35. Nur YA, Groen J, Elmi AM, Ott A, Osterhaus AD. Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia. Epidemiol Infect. 2000; 124(1): 137-41[PubMed]
  • 36. Afzali H, Ardakani AT, Vali GR. Seroepidemiology of hepatitis B and C in blood donors in Kashan, 1996-2001. Feyz J Kashan Unive Med Sci. 2002; 6(3): 43-50
  • 37. Aghamohamad A, Montazeri M, Akbari M. Prevalence of hepatitis B and hepatitis C in blood donors at Semnan province from 2008 to 2011. Koomesh. 2014; 15(2)-7
  • 38. Bozorgi SH, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, et al. Risk factors of viral hepatitis: yet to explore. Transfus Apher Sci. 2012; 47(2): 145-9[DOI][PubMed]
  • 39. Emam Ghoreyshi F, Fathi GE, Mohtashami A. Evaluation of demographic characteristics and hepatitis B, C and HIV prevalence among blood donors in Jahrom. SJIBTO. 2006; 2: 373-8
  • 40. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6(5-6): 1114-6[PubMed]
  • 41. Jabbari H, Karami S, Fattahi F, Jam S, Mohraz M. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses Among Blood Donors in Chabahar Iran. Int J Infec Dis. 2008; 12[DOI]
  • 42. Karimi A, Hoseini S. Seroprevalence of hepatitis B and C virus and HIV markers among blood donors from Shahre-Kord, Iran (2004-2006). Kuwait Med J. 2008; 40(4): 279-81
  • 43. Kasraian L. The prevalence and risk factor of hepatitis B and D in Shiraz blood donors. Africa J Microbiol Res. 2012; 6(18): 3976-9[DOI]
  • 44. Khedmat H, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, Alaeddini F, et al. Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mont. 2009; 2009(1, Winter): 24-8
  • 45. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007; 10(24): 4461-6[PubMed]
  • 46. Maneshi HO, Zare S, Karimi M, Hajiani G. HBV and HCV viral markers seroperevalence in first-time healthy blood donors refered to transfusion centers of bushehr province, South of Iran (April 2004 to March 2008). Retrovirology. 2010; 7[DOI]
  • 47. Ghanaei MF, Falah MS, Jafarshad R, Joukar F, Salari A, Tavaf Zadeh R. Prevalence of hepatitis B and hepatitis C, and their risk factors among Guilan blood donors. Sci J Iran Blood Transfus Organ. 2008; 4(5): 331-6
  • 48. Masaeli Z, Jaberi MR, Magsudlu M. A comparison of seroprevalence of blood-borne infections among regular, sporadic, and first-time blood donors in Isfahan. Sci J Iran Blood Trans Org. 2006; 2(7): 301-7
  • 49. Samadi M, Ghasemzade AH, Sarizade G, Ebrahimi S, Saati S, Abassinejad-Pour A, et al. The comparison of the prevalence rates of HBV, HCV, and HIV in blood donors having deferred for high risk behaviors. Sci J Iran Blood Trans Org. 2014; 10(4)
  • 50. Sorouri Zanjani R, Mazloomzadeh S, Koocheki A, Noori M. Prevalence of Hepatitis B, C and HIV Infection in Blood Donors in Zanjan, 2005-2006. Prevent Care Nurs Midwif J. 2013; 3(1): 56-63
  • 51. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, IR. Iran. Hepat Mon. 2005; 5(4): 117
  • 52. Abdul Mujeeb S, Nanan D, Sabir S, Altaf A, Kadir M. Hepatitis B and C infection in first-time blood donors in Karachi--a possible subgroup for sentinel surveillance. East Mediterr Health J. 2006; 12(6): 735-41[PubMed]
  • 53. Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol. 2005; 5: 26[DOI][PubMed]
  • 54. Asif N, Khokhar N, Ilahi F. Sero-prevalence of HBV, HCV, and HIV infection among voluntary non remunerated & replacement donors in Northern Pakistan. Pakistan J Med Sci. 2004; 20(1): 24-8
  • 55. Attaullah S, Khan S, Khan J. Trend of transfusion transmitted infections frequency in blood donors: provide a road map for its prevention and control. J Transl Med. 2012; 10: 20[DOI][PubMed]
  • 56. Bangash MH, Bangash TH, Alam S. Prevalance of hepatitis B and hepatatis C among healthy blood donors at Kurram agency. J Postgrad Med Inst (Peshawar-Pakistan). 2011; 23(2)
  • 57. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007; 47(1): 74-9[DOI][PubMed]
  • 58. Chaudhry MA, Malik JR, Ashraf MZ. Seropositivity of Hepatitis B and C in Blood Donors at CMH Lahore, Pakistan. APMC. 7(1): 1-5
  • 59. Farooqi JI, Farooqi RJ, Khan N. Frequency of hepatitis B and C in selected groups of population in NWFP, Pakistan. J Postgrad Med Inst (Peshawar-Pakistan). 2011; 21(3)
  • 60. Ijaz R, Bhatti S, Ullah S. Prevalence of hepatitis B and C in healthy blood donors in a peripheral hospital - Ghurki trust hospital, Lahore. Pakistan J Med Health Sci. 2012; 6(3): 568-9
  • 61. Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, et al. Prevalence of hepatitis B in the blood donors of NW. FP and FATA regions and the current scenario of HBV infection in Pakistan. Africa J Biotech. 2013; 9(37): 6162-6
  • 62. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002; 52(9): 398-402[PubMed]
  • 63. Rahman M, Akhtar GN, Lodhi Y. Transfusion transmitted HIV and HBV infections in Punjab Pakistan. Pakistan J Med Sci. 2002; 18(1): 18-25
  • 64. Zaheer H, Saeed U, Waheed Y, Karimi S, Waheed U. Prevalence and Trends of Hepatitis B, Hepatitis C and Human Immunodeficiency Viruses among Blood Donors in Islamabad, Pakistan 2005-2013. J Blood Disorders Transf. 2014; 5(217): 2
  • 65. Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, et al. HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Brazil J Infect Dis. 2010; 14(1): 41-6
  • 66. Akalin S, Baskan B, Sacar S, Sayin Kutlu S, Turgut H. Seroprevalence of HBsAg, Anti-HCV and RPR in Blood Donors in Denizli, Turkey. Klimik Dergisi/Klimik J. 2011; 24(2): 101-4[DOI]
  • 67. Kader C, Erbay A, Birengel S, Gurbuz M. Seroprevalence of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus Infections and Syphilis in Blood Donors. Klimik Dergisi/Klimik J. 2010; 23(3): 95-9[DOI]
  • 68. Mese S, Nergiz S, Tekes S, Gul K. Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey. Clin Ter. 2014; 165(2): 95-8[DOI][PubMed]
  • 69. Mutlu B, Meric M, Willke A. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors]. Mikrobiyol Bul. 2004; 38(4): 445-8[PubMed]
  • 70. Oner S, Yapici G, Sasmaz CT, Kurt AO, Bugdayci R. Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey. Turk J Med Sci. 2011; 41(2): 335-41
  • 71. Sakarya S, Oncu S, Ozturk B, Oncu S. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey. Saudi Med J. 2004; 25(8): 1070-2[PubMed]
  • 72. Turan H, Serefhanoglu K, Kanat-Unler G, Arslan H. Seroprevalance of HBsAg and Anti-HCV and Their Correlation to Age and Gender in Blood Donors in the Province of Konya. Klimik Dergisi/Klimik J. 2011; 24(1): 36-9[DOI]
  • 73. Eissa SA, Abdel Meguid LM, Ebeid SM, Abou Elfetouh RM, Abdel Moneim GM. National Cancer Institute Experience in Healthy Egyptian Blood Donors as Regards Blood Group Frequencies and Seroprevalence of Hepatitis B Virus, Hepatitis C Virus&HIV: 10 Year Evaluation. J Egypt Natl Canc Inst. 2007; 19(1): 71-6[PubMed]
  • 74. El-Gilany AH, El-Fedawy S. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. East Mediterr Health J. 2006; 12(6): 742-8[PubMed]
  • 75. Habil FE, Mahdi WK, Abdelwahab SF, Abdel-Hamid M. Hepatitis B virus genotype D predominates HBsAg-positive egyptian blood donors and is mainly associated with a negative HBeAg serostatus. Intervirology. 2013; 56(5): 278-83[DOI][PubMed]
  • 76. Hussein E. Blood donor recruitment strategies and their impact on blood safety in Egypt. Transfus Apher Sci. 2014; 50(1): 63-7[DOI][PubMed]
  • 77. Ismail AM, Ziada HN, Sheashaa HA, Shehab El-Din AB. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope. Eur J Intern Med. 2009; 20(5): 490-3[DOI][PubMed]
  • 78. Khattab MA, Eslam M, Sharwae MA, Hamdy L. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control. 2010; 38(8): 640-1[DOI][PubMed]
  • 79. Wasfi OA, Sadek NA. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. East Mediterr Health J. 2011; 17(3): 238-42[PubMed]
  • 80. Al-Bahrani A, Panhotra BR. Prevalence of HBsAG and ANTI-HCV antibodies in blood donors of the Al-Hasa Region of Saudi Arabia. Ann Saudi Med. 2001; 21(3-4): 234-5[PubMed]
  • 81. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Saudi Med J. 2003; 24(9): 991-5[PubMed]
  • 82. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol. 2004; 26(3): 225-8[DOI][PubMed]
  • 83. El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008; 12(5): 495-9[DOI][PubMed]
  • 84. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004; 25(1): 26-33[PubMed]
  • 85. Mohammed Abdullah S. Prevalence of hepatitis B and C in donated blood from the jazan region of saudi arabia. Malays J Med Sci. 2013; 20(2): 41-6[PubMed]
  • 86. Panhotra BR, Al-Bahrani A, Ul-Hassan Z. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing. Saudi Med J. 2005; 26(2): 270-3[PubMed]
  • 87. Al-Juboury AWF, Salih H, Al-Assadi MK, Ali AM. Seroprevalence of Hepatitis B and C among blood donors in Babylon Governorate-Iraq. Med J Babylon. 2010; 7(1-2): 121-9
  • 88. Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009. Saudi Med J. 2011; 32(10): 1046-50[PubMed]
  • 89. Alodini AQ. Prevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections among blood donors at Al-Thawra Hospital Sana'a City-Yemen. Yemen J Med Sci. 2014; 6
  • 90. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23(9): 1090-4[PubMed]
  • 91. Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol. 2006; 12(42): 6792-6[PubMed]
  • 92. Münzer ALR. The prevalance of hepatitis b in blood donors in the middle region of Jordan. Gulhane Tip Dergsi (Gtd) Gulhane Med J(Gmj). 2003; : 153
  • 93. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005; 45(12): 1973-80[DOI][PubMed]
  • 94. Irani-Hakime N, Musharrafieh U, Samaha H, Almawi WY. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. Am J Infect Control. 2006; 34(4): 241-3[DOI][PubMed]
  • 95. Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013; 13: 50[DOI][PubMed]
  • 96. Country and Lending Groups.
  • 97. Mbendi Nlombi C, Longo-Mbenza B, Mbendi Nsukini S, Muyembe Tamfum JJ, Situakibanza Nanituma H, Vangu Ngoma D. Prevalence of HIV and HBs antigen in blood donors. Residual risk of contamination in blood recipients in East Kinshasa, Democratic Republic of the Congo [in French]. Med Trop (Mars). 2001; 61(2): 139-42[PubMed]
  • 98. Namululi BA, Guerrieri C, Dramaix MW. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo]. Rev Epidemiol Sante Publique. 2013; 61(2): 139-44[DOI][PubMed]
  • 99. Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009; 7(4): 293-9[DOI][PubMed]
  • 100. Dongdem JT, Kampo S, Soyiri IN, Asebga PN, Ziem JB, Sagoe K. Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009). BMC Res Notes. 2012; 5: 115[DOI][PubMed]
  • 101. Xie DD, Li J, Chen JT, Eyi UM, Matesa RA, Obono MM, et al. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum Infections among Blood Donors on Bioko Island, Equatorial Guinea. PLoS One. 2015; 10(10)[DOI][PubMed]
  • 102. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010; 10(1): 111[DOI]
  • 103. Nagalo MB, Sanou M, Bisseye C, Kabore MI, Nebie YK, Kienou K, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus. 2011; 9(4): 419-24[DOI][PubMed]
  • 104. Giri PA, Deshpande JD, Phalke DB, Karle LB. Seroprevalence of transfusion transmissible infections among voluntary blood donors at a tertiary care teaching hospital in rural area of India. J Family Med Prim Care. 2012; 1(1): 48-51[DOI][PubMed]
  • 105. Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus. 2011; 27(1): 1-6[DOI][PubMed]
  • 106. Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol. 2010; 53(2): 308-9[DOI][PubMed]
  • 107. Rudra S, Chakrabarty P, Hossain MA, Akhter H, Bhuiyan MR. Seroprevalence of Hepatitis B, Hepatitis C, HIV Infections in Blood Donors of Khulna, Bangladesh. Mymensingh Med J. 2010; 19(4): 515-9[PubMed]
  • 108. Karki S, Ghimire P, Tiwari B, Rajkarnikar M. HBsAg serosurveillance among Nepalese blood donors. Ann Trop Med Pub Health. 2008; 1(1): 15[DOI]
  • 109. Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health. 2011; 42(3): 609-15[PubMed]
  • 110. Hahne SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar M. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013; 13: 181[DOI][PubMed]
  • 111. Murphy EL, Lam J, Kaidarova Z, Cyrus S, Busch MP. Prevalence and demographic determinants of hepatitis b virus in first-time us blood donors, 2004-2009. Vox Sanguinis. 2012; 103
  • 112. Mirrezaie SM, Saber HR, Hajibeigi B, Salekmoghaddam E, Abbasian A, Alavian SM. Impact of HBV Vaccination on Prevalence of Hepatitis B Virus Infection Among Volunteer Blood Donors in Tehran-Iran. Shiraz E-Medl J. 2014; 15(2)[DOI]
  • 113. Manzoor I, Hashmi N, Daud S, Ajmal S, Fatima H, Rasheed Z, et al. Seroprevalence of transfusion transmissible infections (TTIS) in blood donors. Biomed. 2009; 25(2): 154-8
  • 114. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009; 13(1): 9-19[DOI][PubMed]
  • 115. Redwan NA, Ahmed MM, Barnawi MB. Prevalence study of Hepatitis B virus (HBV) infection by serological techniques in Jeddah, Saudi Arabia. Life Sci J. 2012; 9: 5442-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments